Earnings · China A-shares
BeOne Medicines Ltd. Class A (688235) earnings
BeOne Medicines Ltd. Class A published its Q3 report on 2026-11-09: net profit +431.80% year on year, +474.35% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +0.92% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-11-09
- Period end
- 2026-09-30
- Net profit YoY
- +431.80%
- Excl. one-offs YoY
- +474.35%
- Net profit QoQ
- +67.46%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.16% | — |
| 3 days | +0.92% | — |
| 7 days | -4.01% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +1.87%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-11-10 | ¥6.06B | +431.80% | +474.35% | +26.81% | 4.16 | 17.27% | +0.92% | — | — |
| 2026 interim report | 2026-08-27 | ¥3.27B | +627.15% | +1017.59% | +26.84% | 2.26 | 9.90% | -3.28% | -11.83% | -2.90% |
| 2026 Q1 report | 2026-05-12 | ¥1.61B | +1801.30% | +810.74% | +31.02% | 1.11 | 5.05% | -4.72% | -13.00% | -12.69% |
| 2025 annual report | 2026-04-15 | ¥1.46B | +129.34% | +126.39% | +40.46% | 1.03 | 5.33% | +1.83% | +0.76% | -3.79% |
| 2025 Q3 report | 2025-11-13 | ¥1.14B | +130.88% | +124.30% | +44.21% | 0.81 | 4.26% | -0.97% | -5.35% | -3.72% |
| 2025 interim report | 2025-08-30 | ¥449.78M | +115.63% | +108.36% | +46.03% | 0.32 | 1.76% | +17.29% | -1.24% | -2.08% |
| 2025 Q1 report | 2025-05-14 | -¥94.50M | +95.05% | +90.41% | +50.17% | -0.07 | -0.38% | -1.06% | +10.17% | +7.79% |
| 2024 annual report | 2025-04-29 | -¥4.98B | +25.87% | +44.44% | +56.19% | -3.64 | -20.20% | +4.94% | +4.17% | +1.59% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
Stock valuations: 688235 · Stock news: 688235
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.